Intercure Financials
| INCR Stock | ILS 498.20 28.80 5.46% |
Intercure |
Understanding current and past Intercure Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intercure's financial statements are interrelated, with each one affecting the others. For example, an increase in Intercure's assets may result in an increase in income on the income statement.
Please note, the presentation of Intercure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Intercure's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Intercure's management manipulating its earnings.
Intercure Stock Summary
Intercure competes with Together Startup, Delek, Teva Pharmaceutical, and El Al. InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011063760 |
| Business Address | 85 Medinat ha |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.intercure.co |
| Phone | (972) 77 460 5012 |
| Currency | ILS - Israeli Shekel |
You should never invest in Intercure without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Intercure Stock, because this is throwing your money away. Analyzing the key information contained in Intercure's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Intercure Key Financial Ratios
Intercure's financial ratios allow both analysts and investors to convert raw data from Intercure's financial statements into concise, actionable information that can be used to evaluate the performance of Intercure over time and compare it to other companies across industries.| Return On Equity | 0.0736 | |||
| Return On Asset | 0.0538 | |||
| Target Price | 40.23 | |||
| Number Of Employees | 350 | |||
| Beta | -0.22 |
Intercure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intercure's current stock value. Our valuation model uses many indicators to compare Intercure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intercure competition to find correlations between indicators driving Intercure's intrinsic value. More Info.Intercure is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Intercure is roughly 1.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intercure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intercure's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Intercure Systematic Risk
Intercure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Intercure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Intercure correlated with the market. If Beta is less than 0 Intercure generally moves in the opposite direction as compared to the market. If Intercure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Intercure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Intercure is generally in the same direction as the market. If Beta > 1 Intercure moves generally in the same direction as, but more than the movement of the benchmark.
Intercure November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Intercure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intercure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intercure based on widely used predictive technical indicators. In general, we focus on analyzing Intercure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intercure's daily price indicators and compare them against related drivers.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 14.45 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 4.91 |
Complementary Tools for Intercure Stock analysis
When running Intercure's price analysis, check to measure Intercure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intercure is operating at the current time. Most of Intercure's value examination focuses on studying past and present price action to predict the probability of Intercure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intercure's price. Additionally, you may evaluate how the addition of Intercure to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |